Distribution of some newer antibiotics within the kidney interstitium: a therapeutic consideration in pyelonephritis.
D000818:Animals; D002509:Cephaloridine / Q000032:analysis / Q000097:blood / Q000378:metabolism* / Q000627:therapeutic use / Q000652:urine; D002512:Cephalothin / Q000032:analysis / Q000097:blood / Q000378:metabolism* / Q000627:therapeutic use / Q000652:urine; D004285:Dogs; D007275:Injections, Intravenous; D007668:Kidney / Q000378:metabolism*; D008196:Lymph / Q000032:analysis; D009268:Nalidixic Acid / Q000032:analysis / Q000097:blood / Q000652:urine; D010400:Penicillin G / Q000032:analysis / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use / Q000652:urine; D011704:Pyelonephritis / Q000188:drug therapy*
D009268:Nalidixic Acid; D002509:Cephaloridine; D010400:Penicillin G; D002512:Cephalothin